Health · Pharma & Biotech · 1 day ago
Brazil approves Wegovy tablets for obesity, but sales date is unknown
Brazil's health regulator approved Wegovy tablets for adult obesity treatment this week.
The medicine is made by Danish company Novo Nordisk and contains semaglutide, which helps regulate appetite and food intake.
It is the first oral drug in Brazil's weight-loss injection class approved for this use.
Sales cannot begin until Brazil's drug-price regulator sets a maximum price, and no price or launch date has been announced.
Novo Nordisk says the tablets should reach pharmacies in the coming quarters.
Unlike the weekly injection, the tablet is taken every day while fasting; the regulator says patients may switch between forms when clinically indicated.
It is intended for adults with obesity, or with overweight and at least one related health condition, alongside dietary changes and physical activity.
Brazil’s health regulator has approved Novo Nordisk’s Wegovy tablets for treating obesity in adults.
The tablet is the first oral medicine in the “weight-loss injection” class approved in Brazil for this use.
There is no confirmed date for sales in Brazil, and the price has not been set.
Before sales can begin, the government’s medicines pricing chamber must set a maximum price.
Novo Nordisk said the tablets should reach pharmacies in the coming quarters.
- Who
- Brazil’s health regulator Anvisa approved the tablets made by Danish pharmaceutical company Novo Nordisk.
- What
- Wegovy tablets were approved to treat obesity in adults.
- When
- This week, according to the article published on November 7, 2026.
- Where
- Brazil.
- Why
- The tablets are approved for obesity treatment and offer an oral alternative to the injectable version.
This story does not have two clearly opposing sides.
The United States became the first country to approve the tablet.
Sales of the tablet began in the United States.
Anvisa approved Wegovy tablets for obesity treatment in Brazil.
- Active ingredient
- Semaglutide
- Brazil sales date
- Not yet set
- Brazil price
- Not yet defined
- Price-setting body
- Câmara de Regulação do Mercado de Medicamentos (CMED)
- Dosing
- Tablet taken daily while fasting; injection given once a week
What people are saying
in the coming quarters